Presage Biosciences

Translational oncology company pioneering drug development with its CIVO platform

placeSeattle, Washington, United States calendar_todayFounded 2008 groups17 employees language presagebio.com

Registered entities

Investor mix

8 investors on record; lead investors include Takeda Ventures, LabCorp, Bristol-Myers Squibb, Takeda.

Investor typeCountShare
Venture capital225%
Accelerator & incubator113%
Other / undisclosed563%
Coming soon